||HLX07 phase I trial
||Henlix Biotech has been awarded the 13th National Award.
||Shanghai Henlius won the awards by IMAPAC.
||HLX06 phase I trial
||HLX10 phase I trial
||"China's top 50 most valuable investment companies"
||HLX20 will start IND in this senson.
||Shanghai Henlius Biotech, Inc. is honored as the annual preeminence of Asia Biotech of 2017.
||HLX20 Phase I trial
||New market value for Shanghai Henlius Biotech, Inc.